EB- Retatrutide

Retatrutide, 10mg/ml

Retatrutide is a groundbreaking triple agonist targeting glucagon receptors, gastric inhibitory polypeptide, and glucagon-like peptide-1, synergistically enhancing insulin secretion, improving glucose homeostasis, and refining appetite modulation.

Retatrutide distinguishes itself from other medications by activating three different receptors, which improves both weight loss and metabolism. One of these receptors, Glucagon, promotes fat burning, resulting in higher calorie expenditure.